Cargando…
Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification
As Type 2 diabetes progresses, treatment is intensified with additional therapies in an effort to manage hyperglycaemia effectively and therefore avoid complications. When greater efficacy is required, options for injectable treatments include glucagon‐like peptide‐1 receptor agonists and insulin, w...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969085/ https://www.ncbi.nlm.nih.gov/pubmed/29478255 http://dx.doi.org/10.1111/dme.13610 |